United Therapeutics Corporation (Nasdaq: UTHR), a public benefit biotechnology company founded in 1996 and headquartered in Silver Spring, Maryland, with co-headquarters in Research Triangle Park, North Carolina, develops and commercializes…
HQ: Silver Spring, MD, United States of Americawww.unither.com
USD591.17-0.36%vs prev. close
Performance
1W
+4.88%
1M
+9.18%
3M
+18.36%
1Y
+28.55%
YTD
+21.77%
Valuation
P/E
22.3
EPS TTM
26.49
Dividend yield
—
Size and risk
Market cap
$25.2B
Beta
0.48
Price history
UTHR price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
United Therapeutics
UTHR
Drug Manufacturers - Specialty & Generic
Mkt cap (USD bn)
25.2
P/E
22.3
Div yld
—
1W
+4.9%
1M
+9.2%
3M
+18.4%
6M
+3.0%
1Y
+28.6%
YTD
+21.8%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
United Therapeutics
UTHR
Drug Manufacturers - Specialty & Generic
25.2
22.3
—
+4.9%
+9.2%
+18.4%
+3.0%
+28.6%
+21.8%
Subscribe to Equity Analytics to compare UTHR with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.